We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
An assessment of the risk that newly emerging tick-borne bacteria present to the UK population.
The characteristics, diagnosis, management and epidemiology of necrotising fasciitis (NF).
The symptoms, diagnosis, management, surveillance and epidemiology of salmonella.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Guidance and responsibilities of the UK's National Reference Laboratory (NRL) for food microbiology.
UK Health Security Agency (UKHSA) culture collections offer a range of products and services for medical science and laboratory healthcare use.
Journal article in International Journal of Systematic and Evolutionary Microbiology
Lines of communication and action to be taken including the Government departments and agencies responsible.
The characteristics, diagnosis and epidemiology of Stenotrophomonas maltophilia.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
The epidemiology, symptoms, diagnosis and management of plague.
Information for clinicians on the characteristics, diagnosis and epidemiology of infections caused by Chlamydia psittaci.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Antibiotic resistance is once again on the rise after declines in the pandemic, with more dangerous strains of bacteria spreading in communities and hospitals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).